MedTrace Logo

Impact of ODYSight in the Management of patientS With imparairEd Visual acuitY

NCT06076785 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-11-07

No results posted yet for this study

Summary

Previous investigations have demonstrated the agreement between OdySight® and standardised methods in the evaluation of near visual acuity. The app allows for remote monitoring of this parameter with tracking changes. In case of decrease in visual acuity, a notification is sent to both patient and ophthalmologist. The aim of this study is to evaluate the medical relevance of OdySight® features in the management of patients suffering from impaired visual acuity.

Conditions

  • Impaired Visual Acuity

Interventions

DEVICE

OdySight

At home measurements of visual acuity through a mobile app.

Sponsors & Collaborators

  • Tilak Healthcare

    lead INDUSTRY

Principal Investigators

  • Bénédicte BROUSSEAU, MD · Centre Ophtalmologique Ophtalliance

  • Maddalena QUARANTA, MD · Centre Ophtalmologique Rabelais

  • Vincent GUALINO, MD · Clinique Honoré Cave

  • Jean-François GIRMENS, MD · Hopital des XV-XX

  • Isabelle FOURNIER, MD · Institut ophtalmologique Sourdille Atlantique

  • Marie-Noëlle GUILLEMOT, MD · Institut ophtalmologique Sourdille Atlantique

  • Jean-François BOULET, MD · Cabinet d'ophtalmologie

  • Pierre-Olivier LAFONTAINE, MD · Centre Ophtalmologique Oculus

  • Joël UZZAN, MD · Clinique Mathilde

  • Viviane VINH, MD · Centre d'Ophtalmologie du Dauphiné

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-27
Primary Completion
2023-12-31
Completion
2024-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06076785 on ClinicalTrials.gov